Alejandro Ezquerra-Osorio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alejandro Ezquerra-Osorio has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Adriana Vergara Suárez
2 shared publications- Luis Augusto Baeza-Herrera
IMSS-Bienestar, Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Mérida 97130, Mexico
2 shared publications - Alain Sánchez Rodríguez1 shared publication
Alejandro Sierra-Gonzalez De Cossio
Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
1 shared publicationAlexandra Arias-Mendoza
Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
1 shared publication- Alexis Zambrano-Zambrano
Internal Medicine, National Medical Center November 20 ISSSTE, Mexico City, MEX
1 shared publication
Latest Publications
- Open Access
- 27 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (5) , 102752
Venous Excess Ultrasound Score and Acute Kidney Injury in Patients With Acute Heart Failure
- 27 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (5) , 102752
Open AccessVenous Excess Ultrasound Score and Acute Kidney Injury in Patients With Acute Heart Failure
- 26 October 2023
- Published by BMJ in Emergency Medicine Journal
- Vol. 40 (11) , 793-802
Murmur in a man with acute myocardial infarction
Physical examination and echocardiographic findings are consistent with:
- 26 October 2023
- Published by BMJ in Emergency Medicine Journal
- Vol. 40 (11) , 793-802
Murmur in a man with acute myocardial infarction
Physical examination and echocardiographic findings are consistent with:
- Open Access
- 6 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33449
Coronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ with a predisposition for women of reproductive age. It is related to a higher risk of cardiovascular events, increasing it up to 50 times in young people, and 30% of deaths are attributed to coronary artery disease. The risk of developing cardiovascular disease in SLE is related not only to traditional cardiovascular risks factors such as advanced age, hypertension, dyslipidemia, and diabetes but also to disease-specific factors, such as degree of activity, autoantibodies, organ damage, and treatment. Accelerated atherosclerosis is one of the main contributors to pathogenesis. Manifestations range from angina to acute myocardial infarction and sudden death. Markers have been studied for the detection of subclinical disease and stratification of these patients, as well as different treatment options to improve the cardiovascular prognosis of the disease.
- 6 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33449
Open AccessCoronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ with a predisposition for women of reproductive age. It is related to a higher risk of cardiovascular events, increasing it up to 50 times in young people, and 30% of deaths are attributed to coronary artery disease. The risk of developing cardiovascular disease in SLE is related not only to traditional cardiovascular risks factors such as advanced age, hypertension, dyslipidemia, and diabetes but also to disease-specific factors, such as degree of activity, autoantibodies, organ damage, and treatment. Accelerated atherosclerosis is one of the main contributors to pathogenesis. Manifestations range from angina to acute myocardial infarction and sudden death. Markers have been studied for the detection of subclinical disease and stratification of these patients, as well as different treatment options to improve the cardiovascular prognosis of the disease.
- Open Access
- 28 March 2022
- Published by Instituto Mexicano del Seguro Social in Archivos de Cardiología de México
- Vol. 91 (4) , 493-499
¿Cómo tratar la hipertensión arterial sistémica? Estrategias de tratamiento actuales
La hipertensión arterial sistémica es una enfermedad que afecta casi a la mitad de la población. Su compleja fisiopatología, que afecta principalmente a los sistemas renal, hormonal, cardiovascular y neurológico, ha permitido tener diferentes estrategias farmacológicas para tratar cada uno de esos sistemas y así regular la tensión arterial. La American Heart Association en el 2017, la European Society of Cardiology en el 2018 y, por último, la International Society of Hypertension en el 2020, publicaron recomendaciones para el diagnóstico, monitoreo y tratamiento de la hipertensión arterial. La definición de tensión arterial normal o hipertensión varía de acuerdo con cada guía. Las recomendaciones en los cambios del estilo de vida son muy similares, al igual que el tratamiento farmacológico mediante inhibidores del sistema renina-angiotensina, antagonistas de canales de calcio y diuréticos tiazídicos y solo en casos seleccionados el uso de antagonistas de la aldosterona o betabloqueadores.
- 28 March 2022
- Published by Instituto Mexicano del Seguro Social in Archivos de Cardiología de México
- Vol. 91 (4) , 493-499
Open Access¿Cómo tratar la hipertensión arterial sistémica? Estrategias de tratamiento actuales
La hipertensión arterial sistémica es una enfermedad que afecta casi a la mitad de la población. Su compleja fisiopatología, que afecta principalmente a los sistemas renal, hormonal, cardiovascular y neurológico, ha permitido tener diferentes estrategias farmacológicas para tratar cada uno de esos sistemas y así regular la tensión arterial. La American Heart Association en el 2017, la European Society of Cardiology en el 2018 y, por último, la International Society of Hypertension en el 2020, publicaron recomendaciones para el diagnóstico, monitoreo y tratamiento de la hipertensión arterial. La definición de tensión arterial normal o hipertensión varía de acuerdo con cada guía. Las recomendaciones en los cambios del estilo de vida son muy similares, al igual que el tratamiento farmacológico mediante inhibidores del sistema renina-angiotensina, antagonistas de canales de calcio y diuréticos tiazídicos y solo en casos seleccionados el uso de antagonistas de la aldosterona o betabloqueadores.
- 1 January 2021
- Published by GRAPHIMEDIC SA DE CV in Acta Médica Grupo Ángeles
- Vol. 19 (2) , 208-213
La gravedad del prurito y su relación con la edad e índice de masa corporal en pacientes con enfermedad renal crónica en terapia de reemplazo renal
- 1 January 2021
- Published by GRAPHIMEDIC SA DE CV in Acta Médica Grupo Ángeles
- Vol. 19 (2) , 208-213
La gravedad del prurito y su relación con la edad e índice de masa corporal en pacientes con enfermedad renal crónica en terapia de reemplazo renal
- 1 January 2020
- Published by GRAPHIMEDIC SA DE CV in Acta Médica Grupo Ángeles
- Vol. 18 (4) , 360-366
Evaluación de la técnica en la toma de presión arterial en un Hospital de Tercer Nivel en México
- 1 January 2020
- Published by GRAPHIMEDIC SA DE CV in Acta Médica Grupo Ángeles
- Vol. 18 (4) , 360-366
Evaluación de la técnica en la toma de presión arterial en un Hospital de Tercer Nivel en México